Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  piroxantrone
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-21 of 21 for your search:
Start Over
Phase II Study of Piroxantrone in Patients with Advanced Renal Cell Carcinoma (Summary Last Modified 03/91)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: ICC-89U3, NCI-T89-0166D, T89-0166
Phase II Study of Piroxantrone in Patients with Stage IV non-Small Cell Lung Cancer (Summary Last Modified 11/90)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: SWOG-8866
Phase II Evaluation of Piroxantrone in Patients with Advanced Renal Cell Carcinoma (Summary Last Modified 02/91)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: SWOG-8945
Phase II Randomized Study of Merbarone vs Piroxantrone in Patients with Metastatic non-Small Cell Bronchogenic Carcinoma
Phase: Phase II
Type: Treatment
Status: Completed
Age: any age
Sponsor: NCI
Protocol IDs: EST-1589
Phase II Trial of Piroxantrone for Advanced Soft-Tissue Sarcomas (Summary Last Modified 08/90)
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-8930
Phase II Evaluation of Piroxantrone in Patients with Pancreatic Adenocarcinoma (Summary Last Modified 01/91)
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: SWOG-8933
Phase II Evaluation of Piroxantrone in Patients with Gastric Carcinoma (Summary Last Modified 01/91)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: SWOG-8936
Phase II Study of Piroxantrone in Patients with Refractory Carcinoma of the Breast (Summary Last Modified 01/92)
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: SWOG-8911
Phase II Randomized Study of Merbarone vs Piroxantrone in Patients with Recurrent Ovarian Cancer (Summary Last Modified 10/91)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: SWOG-8904
Phase II Trial of Piroxantrone in Women with Advanced Breast Cancer Who Have Failed Non-Anthracycline Chemotherapy
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MAYO-903101, NCCTG-903101, NCI-T90-0249C, T90-0249
Phase II Trial of Piroxantrone in Patients with Advanced Endometrial Cancer
Phase: Phase II
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: SWOG-8918
Phase II Study of Piroxantrone in Patients with Advanced Gastric Cancer (Summary Last Modified 09/91)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 16 and over
Sponsor: NCI
Protocol IDs: MDA-DM-91028, NCI-T91-0084C, T91-0084
Phase II Study of Piroxantrone in Patients with Disseminated Malignant Melanoma (Summary Last Modified 08/93)
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: SWOG-9116
Phase II Master Protocol for Advanced or Recurrent Squamous Cell Carcinoma of the Cervix --- Piroxantrone (Summary Last Modified 03/93)
Phase: Phase II
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: GOG-76T
Phase I Study of Chemotherapy with Oxanthrazole in Patients with Advanced Cancer
Phase: Phase I
Type: Treatment
Status: Closed
Age: over 18
Sponsor: NCI
Protocol IDs: JHOC-86091504, NCI-T86-0227C, T86-0227
Phase I Study of Chemotherapy with Oxantrazole in Patients with Cancer (Summary Last Modified 04/90)
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MAYO-860104, NCI-T86-0268C, T86-0268
Phase I Study of Piroxantrone in Patients with Refractory Acute Leukemias or CML in Blast Crisis (Summary Last Modified 06/90)
Phase: Phase I
Type: Treatment
Status: Completed
Age: over 18
Sponsor: NCI
Protocol IDs: JHOC-9005, NCI-T89-0199C, T89-0199
Phase I Study of High-Dose Piroxantrone Alone and in Combination with G-CSF in Patients with Refractory Solid Tumors (Summary Last Modified 08/91)
Phase: Phase I
Type: Treatment
Status: Completed
Age: over 18
Sponsor: NCI
Protocol IDs: NCI-91-C-61B, NCI-MB-266, NCI-T90-0234N, T90-0234
Phase I Trial of Piroxantrone plus GM-CSF in Patients with Advanced Cancer (Summary Last Modified 08/91)
Phase: Phase I
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: ICC-90X1, NCI-T90-0190D, T90-0190
Start Over